Keyword: Food and Drug Administration (FDA)
Markets & Companies
08.05.2014
- Changing Roles - China's far-reaching presence in the manufacture and supply of active pharmaceutical ingredients (APIs) around the world has long been known. However, with the...
News
29.04.2014
- Generics producer Actavis has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Israel's Teva to sell a generic version of Pfizer's...
News
09.04.2014
- Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...
News
28.03.2014
- GlaxoSmithKline (GSK), the UK's largest pharmaceutical company, has provisionally withdrawn its marketing authorization application to the European Medicines Agency (EMA) for the...
News
10.03.2014
- In response to an application by U.S. drugmaker Eli Lilly for approval of a New Drug Application (NDA) for its type 2 diabetes treatment empagliflozin, the U.S. Food and Drug...
News
03.03.2014
- Generic drugmakers are actively campaigning against a rule proposed by the U.S. Food and Drug Administration (FDA) that would require them to change the prescribing information on...
News
20.02.2014
- German pharmaceutical producer Boehringer Ingelheim is being confronted in the U.S. with more than 2,000 lawsuits related to its blood thinner Pradaxa (dabigatran). The plaintiffs...
News
04.02.2014
- Japan's Daiichi Sankyo said it would send personnel to help resolve problems at a production facility of its drugmaking subsidiary Ranbaxy at Toansa in India's northern state of...
